In order to give early access to findings, Nature has just published an unedited version of the manuscript describing the prophylactic and treatment benefit of N-0358 (small molecule compound) for COVID virus and its variants. The authors state that although widespread vaccination against COVID has occurred, emerging variants of concern (VOCs) have reduced the vaccine […]
Search Results for: vaccine
According to a new study conducted by Swedish researchers at Lund University, the messenger RNA (mRNA) from Pfizer’s COVID-19 vaccine is able to enter human liver where it triggers the cell’s DNA, inside the nucleus, to increase the production of the LINE-1 gene expression to make mRNA. Results of the study showed rapid up-take of […]
A new peer reviewed article was published in Cureus that evaluated the use of Ivermectin for prophylaxis of COVID 19 in a city-wide study conducted in Itajaí, Brazil. Study results showed that regular use of ivermectin as a prophylactic was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates. Authors reviewed studies suggesting Ivermectin has […]
This review summarizes the health burden of human babesiosis emerging on a global scale. Authors discuss tools used to monitor the frequency and location of disease as well as demographics, modes of transmission and the location of human babesiosis. Authors further describe the causative Babesia spp. in North and South America, Europe, Asia, Africa, and […]
A recent article published by The Wilderness Medical Society describes evidence-based guidelines for the prevention and management of tick-borne illness. These guidelines were developed on a grade system by an expert panel designated by The Wilderness Medical Society. Panelists were selected based on level of clinical interest or research experience. Evidence for each recommendation was […]
NC Department of Health and Human Services has offered information advising how patients can locate services for monoclonal antibodies treatment for COVID-19 infections. The NCDHHS website states, “The Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID-19 […]
The Lyme Disease Association announces that the Tick IPM Working Group is presenting the second annual Tick Academy, September 13-15, 2021 from 10 AM until 2 PM each day. The Tick Academy is the premier event for educators, students, researchers, pest control professionals, public health professionals, public-space managers, and citizen scientists, who want to learn more about what they can do to stop the spread of ticks and tickborne diseases in their respective communities.
A new protocol for patients suffering from Long Haul COVID-19 Syndrome (LHCS) has been developed in a collaboration led by Dr. Mobeen Syed (“Dr. Been”), Dr. Ram Yogendra, Dr. Bruce Patterson, Dr. Tina Peers, and the Front Line COVID-19 Critical Care Alliance (FLCCC). The protocol, I-RECOVER, is based on the group’s experiences using certain therapies […]
From LDA President Pat Smith’s Blog: When the CDC announced a webinar offering continuing education for health care providers for Lyme Awareness Month, some thought it would provide much needed education for doctors about the reality of Lyme disease for patients and what the CDC could do to actually help. Many thought CDC would seek patient input for this program. So what really happened on the webinar?
The development of a national strategy on vector-borne diseases including tick-borne diseases was mandated by Congress. To inform development of the national strategy to address vector-borne diseases, HHS is issuing this Request for Information (RFI).